Literature DB >> 15878378

Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting.

Tarek M Fahmy1, Robert M Samstein, Casey C Harness, W Mark Saltzman.   

Abstract

We describe a general method for incorporating target ligands into the surface of biocompatible polyester poly(lactic-co-glycolic acid) (PLGA) 50/50 materials using fatty acids. Avidin-fatty acid conjugates were prepared and efficiently incorporated into PLGA. Avidin was chosen as an adaptor protein to facilitate the attachment of a variety of biotinylated ligands. We show that fatty acid preferentially associates with the hydrophobic PLGA matrix, rather than the external aqueous environment, facilitating a prolonged presentation of avidin over several weeks. We successfully applied this approach in both microspheres encapsulating a model protein, bovine serum albumin, and PLGA scaffolds fabricated by a salt-leaching method. Because of its ease, generality and flexibility, this strategy promises widespread utility in modifying the surface of PLGA-based materials for applications in drug delivery and tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15878378     DOI: 10.1016/j.biomaterials.2005.02.025

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  67 in total

1.  A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system.

Authors:  Rebecca L Cook; Kyle T Householder; Eugene P Chung; Alesia V Prakapenka; Danielle M DiPerna; Rachael W Sirianni
Journal:  J Control Release       Date:  2015-10-22       Impact factor: 9.776

2.  Suppression of Murine Lupus by CD4+ and CD8+ Treg Cells Induced by T Cell-Targeted Nanoparticles Loaded With Interleukin-2 and Transforming Growth Factor β.

Authors:  David A Horwitz; Sean Bickerton; Michael Koss; Tarek M Fahmy; Antonio La Cava
Journal:  Arthritis Rheumatol       Date:  2019-03-05       Impact factor: 10.995

3.  Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors.

Authors:  Jiangbing Zhou; Toral R Patel; Michael Fu; James P Bertram; W Mark Saltzman
Journal:  Biomaterials       Date:  2011-10-19       Impact factor: 12.479

Review 4.  Design opportunities for actively targeted nanoparticle vaccines.

Authors:  Tarek M Fahmy; Stacey L Demento; Michael J Caplan; Ira Mellman; W Mark Saltzman
Journal:  Nanomedicine (Lond)       Date:  2008-06       Impact factor: 5.307

5.  An artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the magnitude and direction of the T cell response.

Authors:  Erin R Steenblock; Tarek Fadel; Michael Labowsky; Jordan S Pober; Tarek M Fahmy
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

6.  A dynamic model of chemoattractant-induced cell migration.

Authors:  Hao Yang; Xue Gou; Yong Wang; Tarek M Fahmy; Anskar Y-H Leung; Jian Lu; Dong Sun
Journal:  Biophys J       Date:  2015-04-07       Impact factor: 4.033

Review 7.  Designing bioactive delivery systems for tissue regeneration.

Authors:  Hillary E Davis; J Kent Leach
Journal:  Ann Biomed Eng       Date:  2010-07-30       Impact factor: 3.934

8.  Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates.

Authors:  Jason Park; Thomas Mattessich; Steven M Jay; Atu Agawu; W Mark Saltzman; Tarek M Fahmy
Journal:  J Control Release       Date:  2011-06-24       Impact factor: 9.776

9.  The uptake and intracellular fate of PLGA nanoparticles in epithelial cells.

Authors:  Malgorzata S Cartiera; Katherine M Johnson; Vanathy Rajendran; Michael J Caplan; W Mark Saltzman
Journal:  Biomaterials       Date:  2009-02-20       Impact factor: 12.479

10.  Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus.

Authors:  Yen Cu; W Mark Saltzman
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.